Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) – Equities researchers at William Blair issued their Q3 2022 earnings estimates for shares of Apollo Medical in a research note issued to investors on Wednesday, September 21st. William Blair analyst R. Daniels anticipates that the company will post earnings per share of $0.20 for the quarter. William Blair currently has a "Outperform" rating on the stock. William Blair also issued estimates for Apollo Medical's Q4 2022 earnings at $0.26 EPS, FY2022 earnings at $1.02 EPS, FY2023 earnings at $1.18 EPS, FY2024 earnings at $1.44 EPS and FY2025 earnings at $1.91 EPS.
Get
Apollo Medical alerts:
Separately, Barclays lifted their target price on shares of Apollo Medical from $50.00 to $57.00 and gave the stock an "equal weight" rating in a research note on Monday, August 8th.
Apollo Medical Stock Up 1.3 %
NASDAQ:AMEH opened at $41.09 on Friday. Apollo Medical has a fifty-two week low of $29.52 and a fifty-two week high of $133.23. The stock has a market capitalization of $2.32 billion, a P/E ratio of 25.68 and a beta of 0.75. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.49 and a current ratio of 2.49. The company's 50-day simple moving average is $46.62 and its 200-day simple moving average is $42.49.
Hedge Funds Weigh In On Apollo Medical
Institutional investors have recently bought and sold shares of the business. Legal & General Group Plc increased its holdings in shares of Apollo Medical by 2.7% during the 2nd quarter. Legal & General Group Plc now owns 92,916 shares of the company's stock valued at $3,586,000 after purchasing an additional 2,408 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in Apollo Medical by 21.8% in the 2nd quarter. Thrivent Financial for Lutherans now owns 37,445 shares of the company's stock worth $1,445,000 after acquiring an additional 6,695 shares in the last quarter. AQR Capital Management LLC raised its position in Apollo Medical by 26.7% during the second quarter. AQR Capital Management LLC now owns 8,129 shares of the company's stock worth $314,000 after acquiring an additional 1,713 shares during the period. State Street Corp raised its position in Apollo Medical by 4.3% during the second quarter. State Street Corp now owns 1,276,787 shares of the company's stock worth $49,271,000 after acquiring an additional 52,716 shares during the period. Finally, Cubist Systematic Strategies LLC raised its position in shares of Apollo Medical by 199.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 16,386 shares of the company's stock worth $632,000 after purchasing an additional 10,920 shares during the last quarter. 32.03% of the stock is owned by hedge funds and other institutional investors.
About Apollo Medical
(Get Rating)
Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories
- Get a free copy of the StockNews.com research report on Apollo Medical (AMEH)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.
